What are the recommendations for early risk stratification of NSTE-ACS?
Early risk stratification of NSTE-ACS is recommended to assess the level of risk. This assessment includes taking into account the patient's demographics and history, electrocardiogram, physical examination, and cardiac biomarkers. It is important to note that high, intermediate, and low risk levels should be considered when stratifying the patient's risk. Additionally, it is recommended that anti-ischemic and analgesic medications, as well as oxygen therapy, are used for the initial management of NSTE-ACS.